| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 17. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | midazolam (Ozalin®) |
| Formulation | 2 mg/ml oral solution |
| Reference number | 4127 |
| Indication | In children from 6 months to 17 years, for moderate sedation before a therapeutic or diagnostic procedure or as premedication before anaesthesia |
| Company | Sintetica Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 14/05/2019 |